NDC 0338-9640
Vasopressin in 0.9% Sodium Chloride 20 [USP'U] per 100 mL injection
On the label: Baxter Healthcare Corporation.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation | Round Lake, IL, United States | Makes it, tests it, packages it, labels it and sterilizes it | Serious problems, FDA actionApr 2, 2026 · 15 inspections, 2 with FDA action |
Recalls
- Aug 6, 2026 · Class II · Baxter Healthcare Corporation
CGMP Deviations
Lots: Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028. - Aug 6, 2026 · Class II · Baxter Healthcare Corporation
CGMP Deviations
Lots: Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Vasopressin: every company that makes it
- Form
- injection, intravenous
- Strength
- 20 [USP'U] per 100 mL
- Approval
- NDA NDA217569
- On the market since
- Sep 29, 2023
- Package NDCs
0338-9640-12- Official label
- DailyMed (National Library of Medicine), updated Feb 21, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?